Press Releases

May 21, 2024

PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease

Nov 15, 2023

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.

Oct 31, 2023

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

Jun 15, 2023

PharmaCyte Biotech Announces Final Results of Tender Offer

May 11, 2023

PharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per Share

Feb 2, 2023

PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

Oct 7, 2022

PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value

Aug 15, 2022

PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

Jul 28, 2022

PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation

Jul 21, 2022

PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

1
2
3
4
5
6
7
8
9
10
...30
Next »